Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Reiss M. Freddie — INTRABIOTICS PHARMACEUTICALS INC /DE insider: 1 transactions · InsiderLens

Home / Insiders / Reiss M. Freddie

Reiss M. Freddie

Director at AMYRIS, INC. · on record since Aug 17, 2023
Director at SPECIAL VALUE OPPORTUNITIES FUND LLC · on record since Feb 12, 2014
Director at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Apr 20, 2016
Director at Special Value Continuation Fund, LLC · on record since Aug 24, 2016
Supervisory Board Member at Woodbridge Liquidation Trust · on record since Dec 26, 2019
Director at BlackRock Direct Lending Corp. · on record since Feb 8, 2021

Insider trading activity of Reiss M. Freddie

Transactions on record: 1; since Apr 20, 2016

Open-market buys: 1; $33.5K

Open-market sells: 0

Companies traded: 1; last filing Apr 20, 2016

Figures computed from official regulatory filings — methodology.

Companies where Reiss M. Freddie has traded

INTRABIOTICS PHARMACEUTICALS INC /DE1 tx · $33.5K · Apr 20, 2016

Track record of Reiss M. Freddie

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Reiss M. Freddie

Co-insiders of Reiss M. Freddie

Greenwood ElizabethBlackRock Direct Lending Corp. +2
CHANG STEVEN CSpecial Value Continuation Fund, LLC +1
Cuellar Erik L.BlackRock Direct Lending Corp. +1
Davis Paul LSpecial Value Continuation Fund, LLC +1
DRAUT ERIC JOHNBlackRock Direct Lending Corp. +1
Feliciano Jose EnriqueSpecial Value Continuation Fund, LLC +1
Hazzard Ariel TiffanyBlackRock Direct Lending Corp. +1

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

HOLDSWORTH MARKSpecial Value Continuation Fund, LLC +1

JOHNSON FRANKLINSpecial Value Continuation Fund, LLC +1

Leets Karen LBlackRock Direct Lending Corp. +1

LEVKOWITZ HOWARDSpecial Value Continuation Fund, LLC +1

Mehring JasonBlackRock Direct Lending Corp. +1

Pagel Eric RichardSpecial Value Continuation Fund, LLC +1

Park CharlesBlackRock Direct Lending Corp. +1

Schwab Peter EBlackRock Direct Lending Corp. +1

Singhal NikBlackRock Direct Lending Corp. +1

SVOF/MM, LLCSpecial Value Continuation Fund, LLC +1

TENNENBAUM CAPITAL PARTNERS LLCSpecial Value Continuation Fund, LLC +1

TENNENBAUM & CO LLCSpecial Value Continuation Fund, LLC +1

TENNENBAUM MICHAEL ESpecial Value Continuation Fund, LLC +1

Tseng Philip MBlackRock Direct Lending Corp. +1

Urrutia Pedro MartinSpecial Value Continuation Fund, LLC +1

Usifer Maureen KBlackRock Direct Lending Corp. +1

Vig RajneeshBlackRock Direct Lending Corp. +1

Williams Karyn LeighBlackRock Direct Lending Corp. +1

Wolfe PatrickBlackRock Direct Lending Corp. +1

Worrell August DanielBlackRock Direct Lending Corp. +1

Wruble Brian FSpecial Value Continuation Fund, LLC +1

14159 capital (GP), LLCINTRABIOTICS PHARMACEUTICALS INC /DE

AISG GP Ltd.INTRABIOTICS PHARMACEUTICALS INC /DE

ALBRECHT DETLEFINTRABIOTICS PHARMACEUTICALS INC /DE

Alexander RalphAMYRIS, INC.

Al Thani Sheikh Abdullah bin KhalifaAMYRIS, INC.

ALVAREZ EDUARDOAMYRIS, INC.

ANDREEFF DANEINTRABIOTICS PHARMACEUTICALS INC /DE

Apollo Capital Management GP, LLCINTRABIOTICS PHARMACEUTICALS INC /DE

Apollo Capital Management, L.P.INTRABIOTICS PHARMACEUTICALS INC /DE

Apollo Management Holdings GP, LLCINTRABIOTICS PHARMACEUTICALS INC /DE

Apollo Management Holdings, L.P.INTRABIOTICS PHARMACEUTICALS INC /DE

Arduini Charles JRINTRABIOTICS PHARMACEUTICALS INC /DE

ARES CAPITAL MANAGEMENT II LLCINTRABIOTICS PHARMACEUTICALS INC /DE

Ares Holdings LLCINTRABIOTICS PHARMACEUTICALS INC /DE

ARES INVESTMENTS HOLDINGS LLCINTRABIOTICS PHARMACEUTICALS INC /DE

ARES INVESTMENTS LLCINTRABIOTICS PHARMACEUTICALS INC /DE

Ares Management Holdings LLCINTRABIOTICS PHARMACEUTICALS INC /DE

ARES MANAGEMENT LLCINTRABIOTICS PHARMACEUTICALS INC /DE

Ares Partners Holdco LLCINTRABIOTICS PHARMACEUTICALS INC /DE

ARES PARTNERS MANAGEMENT CO LLCINTRABIOTICS PHARMACEUTICALS INC /DE

ARUNACHALAM USHAINTRABIOTICS PHARMACEUTICALS INC /DE

ASADORIAN RAFFIAMYRIS, INC.

Company	Filed	Type	Qty	Price	Value · USD	Src
INTRABIOTICS PHARMACEUTICALS INC /DE	Apr 20, 2016	Buy	2,500	13.40 USD	$33.5K	SEC